IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $253,483 | +12.0% | 6,178 | +3.1% | 0.04% | -28.8% |
Q4 2022 | $226,242 | -3.3% | 5,990 | +13.2% | 0.06% | +25.5% |
Q3 2022 | $234,000 | +15.8% | 5,290 | -3.1% | 0.05% | -42.0% |
Q2 2022 | $202,000 | -65.5% | 5,457 | -65.5% | 0.08% | +3.8% |
Q1 2022 | $585,000 | -42.9% | 15,796 | -26.9% | 0.08% | -64.9% |
Q3 2020 | $1,025,000 | +8.2% | 21,600 | +85.1% | 0.22% | +344.0% |
Q1 2019 | $947,000 | – | 11,670 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |